Comparative evaluation of the clinical and radiographic efficacy of 0.05% Zoledronate gel as local drug delivery system in treating intrabony defects in stage III grade B periodontitis patients with and without type-2 diabetes mellitus - A randomized split-mouth clinical trial.

ZLN gel applied subgingivally in infrabony pockets resulted in significant clinical improvements evident by probing depth reduction and gain in attachment levels along with radiographic evidence of more bone fill seen in non-diabetic patients compared to diabetic periodontitis patients. This article is protected by copyright. All rights reserved.